Monocytosis in myelofibrosis is associated with clinical outcome, hematologic abnormalities and somatic mutations
Myelofibrosis is a chronic myeloproliferative neoplasm that has a heterogenous clinical phenotype and prognosis. Current prognostic models use a variety of clinical and laboratory characteristics to define risk groups whose median survivals can differ by nearly a decade. Prior investigations have suggested a negative prognostic role of absolute monocytosis in this disease.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Daniel Kerr, Andrew Kuykendall, Chetasi Talati, Najla Al-Ali, David Sallman, Kendra Sweet, Jeffrey Lancet, Alan List, Eric Padron, Rami Komrokji Source Type: research